Mark Schoenberg, Chief Medical Officer at UroGen Pharma Ltd. (URGN), sold 111 shares at $8.09 ($898) on 2022-01-26, disclosed to the SEC on 2022-01-28.
Open-market sale of $898 URGN by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| URGN | SELL | 2026-07-10 | $400K | — | Filing → |
| URGN | SELL | 2026-06-24 | $350K | — | Filing → |
| URGN | SELL | 2026-06-09 | $143K | — | Filing → |